Advertisement

Ketamine as a Potential Transdiagnostic Treatment for Anhedonia?

  • Benjamin Becker
    Correspondence
    Address correspondence to Benjamin Becker, Ph.D.
    Affiliations
    Clinical Hospital of Chengdu Brain Science Institute, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, China
    Search for articles by this author
      SEE CORRESPONDING ARTICLE ON PAGE 285
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

        • Halahakoon D.C.
        • Kieslich K.
        • O’Driscoll C.
        • Nair A.
        • Lewis G.
        • Roiser J.P.
        Reward-processing behavior in depressed participants relative to healthy volunteers: A systematic review and meta-analysis.
        JAMA Psychiatry. 2020; 77: 1286-1295
        • Malhi G.S.
        • Mann J.J.
        Depression.
        Lancet. 2018; 392: 2299-2312
        • Warden D.
        • Rush A.J.
        • Trivedi M.H.
        • Fava M.
        • Wisniewski S.R.
        The STAR∗D Project results: A comprehensive review of findings.
        Curr Psychiatry Rep. 2007; 9: 449-459
        • Argyropoulos S.V.
        • Nutt D.J.
        Anhedonia revisited: Is there a role for dopamine- targeting drugs for depression?.
        J Psychopharmacol. 2013; 27: 869-877
        • Berman R.M.
        • Cappiello A.
        • Anand A.
        • Oren D.A.
        • Heninger G.R.
        • Charney D.S.
        • et al.
        Antidepressant effects of ketamine in depressed patients.
        Biol Psychiatry. 2000; 47: 351-354
        • Zarate Jr., C.A.
        • Singh J.B.
        • Carlson P.J.
        • Brutsche N.E.
        • Ameli R.
        • Luckenbaugh D.A.
        • et al.
        A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
        Arch Gen Psychiatry. 2006; 63: 856-864
        • Ballard E.D.
        • Wills K.
        • Lally N.
        • Richards E.M.
        • Luckenbaugh D.A.
        • Walls T.
        • et al.
        Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials.
        J Affect Disord. 2017; 218: 195-200
        • Kotoula V.
        • Stringaris A.
        • Mackes N.
        • Mazibuko N.
        • Hawkins P.C.T.
        • Furey M.
        • et al.
        Ketamine modulates the neural correlates of reward processing in unmedicated patients in remission from depression.
        Biol Psychiatry Cogn Neurosci Neuroimaging. 2022; 7: 285-292

      Linked Article